Fredun Pharmaceuticals Ltd (FREDUN) — Announcement | 4 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Fredun Pharmaceuticals launches PAWTALKS platform for pet healthcare conversations

Fredun Pharmaceuticals Limited announced the launch of PAWTALKS, a new platform for pet and animal healthcare conversations, aiming to unite experts and pet parents through educational content and community engagement, targeting growth in India's expanding pet care market.

📄 View Original Announcement (PDF)

About Fredun Pharmaceuticals Ltd (FREDUN)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹2,020.29 Cr P/E: 14.3 ROE: 16.6% ROCE: 20.5% Div Yield: 0.06%

View full FREDUN stock details →

📡 Get AI alerts when FREDUN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FREDUN — Free

📊 More FREDUN filings

See all FREDUN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FREDUN files new disclosures

Track FREDUN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FREDUN — Free

Free account · 2 AI queries/day